HomeABCL • NASDAQ
add
AbCellera Biologics Inc
Nakaraang pagsara
$3.48
Sakop ng araw
$3.27 - $3.46
Sakop ng taon
$2.34 - $5.62
Market cap
983.57M USD
Average na Volume
3.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.51M | -1.39% |
Gastos sa pagpapatakbo | 59.20M | 151.15% |
Net na kita | -51.11M | -78.63% |
Net profit margin | -785.42 | -81.16% |
Kita sa bawat share | -0.17 | -70.00% |
EBITDA | -56.74M | -15.44% |
Aktuwal na % ng binabayarang buwis | 18.40% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 643.14M | -18.16% |
Kabuuang asset | 1.39B | -7.89% |
Kabuuang sagutin | 314.73M | -4.46% |
Kabuuang equity | 1.08B | — |
Natitirang share | 295.37M | — |
Presyo para makapag-book | 0.95 | — |
Return on assets | -16.69% | — |
Return on capital | -20.08% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -51.11M | -78.63% |
Cash mula sa mga operasyon | -28.88M | -27,147.17% |
Cash mula sa pag-invest | 3.70M | 128.92% |
Cash mula sa financing | 3.14M | -52.56% |
Net change in cash | -21.67M | -195.86% |
Malayang cash flow | -10.48M | 72.64% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
586
